Astaxanthin protects cognitive function of vascular dementia

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Vascular dementia (VD) is a debilitating condition characterized by cognitive decline.
• Inflammatory responses and oxidative stress are key contributors to VD pathogenesis.
• Current treatments for VD have limited efficacy.

Purpose of the Study:

• To investigate the neuroprotective effects of astaxanthin (AST) in a mouse model of vascular dementia.
• To assess AST's impact on cognitive function, neuroinflammation, and oxidative stress markers in VD mice.

Main Methods:

• A vascular dementia mouse model was induced using left unilateral common carotid arteries occlusion (LUCCAO).
• Astaxanthin was administered intragastrically for 30 days post-LUCCAO.
• Cognitive function was evaluated using object recognition and Morris water maze tests. Hippocampal histology, IL-1β, IL-4, SOD, and MDA levels were analyzed.

Main Results:

• Astaxanthin administration improved spatial learning and memory in VD mice.
• AST treatment significantly reduced hippocampal and prefrontal cortex levels of the pro-inflammatory cytokine IL-1β and malondialdehyde (MDA).
• AST treatment increased levels of the anti-inflammatory cytokine IL-4 and superoxide dismutase (SOD) activity in a dose-dependent manner, while alleviating neuronal damage.

Conclusions:

• Astaxanthin demonstrates significant therapeutic potential for improving cognitive impairment in vascular dementia.
• AST's neuroprotective effects are likely mediated through the suppression of inflammatory pathways and oxidative stress.
• Further research into AST as a treatment for VD is warranted.